High-Risk Non-Muscle Invasive Bladder Cancer

Explore clinical trials studying High-Risk Non-Muscle Invasive Bladder Cancer. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

High-Risk Non-Muscle Invasive Bladder Cancer trial results

Recruiting

NCT06378242

Conditions: High-Risk Non-Muscle Invasive Bladder Cancer
Locations: Sun Yat-sen Memorial Hospital,SunYat-sen University Guangzhou, Guangdong, China

Tongji Hospital Wuhan, Hubei, China

Hunan Cancer hospital Changsha, Hunan, China

The first affiliated hospital with nanjing medical universtity Nanjing, Jiangsu, China

Not Yet Recruiting

NCT07268339

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: The Christie Manchester, United Kingdom

Active, Not Recruiting

NCT03711032

Conditions: High-Risk Non-Muscle Invasive Bladder Cancer, Parkinson Disease 4, Autosomal Dominant Lewy Body
Locations: Alaska Urological Institute dba Alaska Clinical Research Center ( Site 1083) Anchorage, Alaska, United States

Mayo Clinic in Arizona - Phoenix ( Site 1094) Phoenix, Arizona, United States

Del Sol Research Management, LLC ( Site 1096) Tucson, Arizona, United States

UCLA Hematology/Oncology - Westwood (Building 200 Suite 140)-Department of Urology/Institute of Uro ( Site 1052) Los Angeles, California, United States

View all 209 locations